BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy.
BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy.
Oncotarget. 2018 Oct 19;9(82):35291-35292
Authors: Nougarède A, Rimokh R, Gillet G
PMID: 30450157 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research